Skip to main navigation
Skip to search
Skip to main content
Uniformed Services University Home
Home
Profiles
Research units
Research output
Projects
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A PHASE 2 TOLERANCE TRIAL OF BELATACEPT AND ALEMTUZUMAB IN RENAL TRANSPLANTATION
Kirk, Allan
(PI)
Surgery
Emory University
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Abatacept
100%
Alemtuzumab
98%
Sirolimus
60%
Immunosuppressive Agents
58%
Kidney Transplantation
53%
Transplantation
43%
Immunosuppression
38%
Allografts
37%
Tissue Donors
33%
Bone Marrow
31%
T-Lymphocytes
26%
Animal Models
20%
Lymphocyte Depletion
20%
Transplantation Tolerance
19%
Immune Reconstitution
18%
Pharmaceutical Preparations
17%
Blood Donors
14%
Transplant Recipients
13%
Chronic Kidney Failure
12%
Therapeutics
11%
Immune System
11%
Monoclonal Antibodies
10%
Clinical Trials
9%
Transplants
8%
Biopsy
8%
Drug Therapy
8%
Kidney
7%
Proteins
5%